Alton Oliver Sartor, Louise Emmett, Karim Olivier Fizazi, Andrei Iagaru, Ana Ponce Kiess, Nobuaki Matsubara, Josep M. Piulats, Fred Saad, Scott T. Tagawa, Xiao X. Wei, Jun Tang, Shaheen Alanee, Jeremie Calais. "AcTFirst: A phase 3 trial of
                    <sup>225</sup>
                    Ac-PSMA-617 plus ARPI versus standard of care in adults with PSMA-positive metastatic castration-resistant prostate cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5134